Functionality, comorbidity, complication & surgery of hip fracture in older adults by age distribution INTRODUCTION Worldwide, hip fractures may be considered as the major complication in terms of morbid-mortality and economic burden secondary to the osteoporotic disorder. 1 Regarding the southern European population, a high prevalence and incidence were observed in Spain, especially regarding trochanteric fractures, female gender and ages over 85 years.
2,3
the community with the highest incidence of HF in Spain. Methods data about age, gender, type of fracture and month of hospitalisation among patients aged 65 years and older discharged with a diagnosis of HF were collected. Crude and age-standardised annual incidence rate were reckoned. To analyse HF trend, the age/sex-adjusted average annual change in incidence (incidence rate ratio, IRR Furthermore, the relationship between age and mortality after a hip fracture in older adults may reach 5.5% and can be associated with several comorbidities, such as con-gestive heart failure, metastasis, fluid and electrolyte disorders, coagulation deficiencies, or liver disease. 4 Indeed, older adults who suffered hip fractures in a hospital may present a worse surgical (grade III and IV of the American Association of Anesthesiologists -ASA score) and mortality risk than those who suffered hip fractures in the community. 5 Medical treatments associated to hip fracture can comprise conservative or invasive procedures. 6 The conservative treatment may produce a high rate of mobility, mortality and local complications. 7 Whereas, surgical intervention (overall hemiarthroplasty and total hip arthroplasty) may be the first line of treatment in older adults with a hip fracture, since it allows for an earlier mobilization and reduces complications such as respiratory, infection, circulatory or wound conditions.
8
After a hip fracture, older adults showed the reductions in quality of life and functionality due to associated balance and mobility impairments. Consequently, this suggested that the majority of these older adults did not return to their pre-fracture lifestyle.
9 Therefore, the objective of this study was to determine the influence of age distribution in the functionality, comorbidity, complications and surgical features of hip fractures in older adults.
METHODS

Design
A prospective cohort study was carried out from December 2013 to November 2014. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines were considered.
10
Ethical considerations
The study was approved by the Clinical Research Ethics Committee of the León University (Spain; code ÉTICA-ULE-004-2015). An informed written consent form was obtained from all participants before their inclusion in the research study. Furthermore, the Helsinki Declaration, Protection Data Organic Law (15/1999) and ethical standards in human experimentation were respected.
Sample size Based on the hip fracture incidence in Spain, Azagra et al. 11 showed a similar rate of 517 new hip fractures from 100,000 older adults per year. Considering the assumed 4% error for a possible loss in follow-up, 534 participants were necessary to justify the sample size.
Participants
A sample of 557 older adults with hip fracture was recruited from the Traumatology Unit of the León University Hospital, León (Spain). A consecutive sampling method was used to select the participants in the present study.
The inclusion criteria were: adults over 75 years old who suffered an osteoporotic hip fracture from December 1 st of 2013, to November 31 of 2014 recruited from the Orthogeriatric Unit of the León University Hospital.
1
The exclusion criteria were: pathological fractures secondary to other conditions different from osteoporosis (such as neoplasia or osteomyelitis)
, 12 traumatic fractures,
13
treatment type, and inpatient mortality of traumatic hip fractures are important health policy issues. We showed that insurance status and treatment in university hospitals were significantly associated with treatment type (i.e., primary hip replacement or periprosthetic fractures.
14
Procedure ant outcomes
All data were extracted from the medical records by the same authorized investigator (SJM). Age distributions of 75-84, 85-90 and > 90 years old were considered. 4 Firstly, data on sociodemographic (age and gender), fracture type (subcapital or pertrochanteric fractures), total number of hospital staying days and before the surgery were collected. Finally, complications (anemia, transfusion, delirium, constipation, renal function alteration, urinary tract infection, infection or respiratory insufficiency, malnutrition, heart failure, acute retention of urine, ischemic heart disease, death, pressure ulcers, seroma, surgical wound infection, ictus, venous thrombosis or thromboembolism), 20 and features at hospital discharge (destination, home move, ambulation and discharge) were observed.
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STATISTICAL ANALYSIS
Statistical analysis was performed using the statistical package SPSS 22.0 (IBM SPSS Inc., Chicago. IL, USA). A confidence interval (CI) of 95% and a P-value < .05 were considered statistically significant. The sample was divided into 3 age distributions (75-84, 85-90 and > 90 years old) in order to determine differences between these groups. 4 Initially, normality analysis were performed by the Kolmogorov-Smirnov test. Then, a descriptive analysis of the data was carried out. For the quantitative variables, the mean and standard deviation (SD) as well as the one-factor analysis of variance (ANOVA) were calculated for the total number of hospital staying days and before surgery. For the rest of qualitative outcomes, percentage and frequency as well as the Chi-square (χ 2 ) test were used. The effect size was calculated by the R 2 coefficient (slight ~ .050; moderate ~ .150; high ~ .250; large ~ .360; and very large ~ .450).
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RESULTS
A sample of 557 participants with hip fractures were received during the follow-up. Periprosthetic fractures (n = 19) and pathological fractures (n = 4) were excluded. From the remaining participants (n = 534), 31 (5.8%) older adults expired during admission, and 6 (1.1%) were referred to a different hospital for the intervention (n = 497). Age distributions of 75-84 (n = 189; 46 men and 143 women; 94 subcapital and 95 pertrochanteric fractures), 85-90 (n = 180; 47 men and 133 women; 78 subcapital and 102 pertrochanteric fractures) and > 90 (n = 165; 42 men and 123 women; 68 subcapital and 97 pertrochanteric fractures) did not show any statistically-significant differences for gender (χ 2 = 0.16; P = .924; R 2 = .000) or fracture type (χ 2 = 2.87; P = .238; R 2 = 0.005), as well as for total of hospital staying days (F = 0.08; P = .921; R 2 = .000), mean (SD) varied from 11.15 (6.12) to 11.43 (7.84) days, and before surgery (F = 0.32; P = .726; R 2 = .001), mean (SD) varied 5.76 (3.52) from to 6.13 (4.70) days.
Regarding baseline functionality and comorbidities (Table 1) , statistically-significant differences between age distributions were observed for Barthel index (χ 2 = 35.06; P < .001; R 2 = .062), cognitive impairment (χ 2 = 31.28; P = < .001; R 2 = .055), dementia (χ 2 = 8.60; P = .014; R 2 = .016), osteoporosis (χ 2 = 6.07; P = .048; R 2 = .011), Parkinson's disease (χ 2 = 6.35; P = .048; R 2 = .012) and aortic stenosis (χ 2 = 7.08; P = .029; R 2 = .013). All other measurements did not show any statistically-significant difference (P > .05; R 2 = .000 -.007).
Considering surgical features and baseline pharmacologic treatments (Table 2) , statistically-significant differences between age ranges were found for surgery type (χ 2 = 88.34; P < .001; R 2 = .151), ASA score (χ 2 = 12.22; P = .016; R 2 = .023), non-surgical cause (χ 2 = 14.53; P = .024; R 2 = .247), benzodiazepines (χ 2 = 13.29; P = .001; R 2 = .025), antidementia (χ 2 = 6.77; P = .034; R 2 = .013), anti-osteoporosis (χ 2 = 5.60; P = .049; R 2 = .011) and insulin (χ 2 = 9.51; P = .009; R 2 = .018) pharmacologic treatments. The rest of measurements did not show any statistically significant difference (P > .05; R 2 = .000 -.010). With respect to complications and features at hospital discharge (Table 3) , statistically-significant differences between age groups were observed for renal function alteration (χ 2 = 8.99; P = .011; R 2 = .017), heart failure (χ 2 = 7.08; P = .029; R 2 = .013), destination (χ 2 = 19.22; P = .004; R 2 = .038) and ambulation (χ 2 = 19.14; P = .004; R 2 = .037) features. All other measurements did not show any statistically significant difference (P > .05; R 2 = .001 -.009). NS = Non statistically significant different with P > .05. *Statistically significant differences with P < 0.05. ** = Statistically significant differences with P < 0.01. † = Chi square test (χ 2 ) was applied, Bold numbers determine the most significant contribution. Abbreviations: COPD, chronic obstructive pulmonary disease; Df, degrees of freedom.
DISCUSSION
The present study supports novel evidence on functionality, comorbidity, complications and surgical features of hip fractures in older adults over 75 years old by age distribution. It determines the key points to consider in the aging process of older adults during and after hip fracture. All sociodemographic data, fracture type and hospital staying days were representative of the general population of Spain and in accordance to prior studies.
11,23,24
Considering baseline functionality and comorbidities (Table 1) , there were only slight effects observed for the Barthel index, cognitive impairment, dementia, osteoporosis, Parkinson's disease and aortic stenosis. Therefore, independence, osteoporosis, aortic stenosis and Parkinson's disease may be more frequent in younger age distributions of older adults, while cognitive impairment and dementia seemed to be presented in older adults over 85 years old, coinciding with previous researches.
4,15,17 Furthermore, Parkinson's disease may decrease in the older elderly patients, since it may be considered a neurodegenerative condition with associated life expectative reduction.
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Regarding surgical features and baseline pharmacologic treatments (Table 2) , high effects were observed for surgery type, non-surgical cause, and insulin pharmacologic treatment, while slight effects were determined for ASA score, benzodiazepines, antidementia and anti-osteoporosis drugs. Partial bipolar prosthesis and monopolar prosthesis seemed to be more common in older adults over 90. 8 Moreover, the IV -ASA score did not seem to variate with age distribution. Nevertheless, the II and III -ASA scores may be associated with 75-84 and 85-90 age groups, respectively. Therefore, increased age is not associated with higher surgical risk in geriatric hip fracture patients. 24 Anti-dementia and benzodiazepines may be more frequent in nonagenarian patients, while anti-osteoporosis and insulin seemed to be more common in the 75-84 age group. In this (7) 1.2% (2) 9.51 2 .009** .018 NS = Non statistically significant different with P > .05. *Statistically significant differences with P < 0.05. ** = Statistically significant differences with P < 0.01. † = Chi square test (χ 2 ) was applied, Bold numbers determine the most significant contribution. Abbreviations: ASA, American Association of Anesthesiologists -ASA scores (II -Moderate Systemic Disease; III -Severe Non-disabling Systemic Disease; IV -Severe Vital-risk Systemic Disease); Df, degrees of freedom. sense, some authors have claimed a higher risk of hip fracture in older adults with hypnotic pharmacologic treatment.
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Finally, complications and features at hospital discharge (Table 3) showed only slight effects for renal function alteration, heart failure, destination and ambulation features. Coinciding with this, other authors reported kidney function alteration as a frequent complication in older adults with hip fracture.
27 Additionally, ambulation and lifestyle characteristics may be more dependent in the nonagenarian patients as it was reported by previous authors.
28
Some limitations should be considered in the present study; despite the age distributions over 75 years old seemed to show the greatest prevalence of hip fracture and presented a similar number among participants in our study, the considered age ranges were not equal.
1 Indeed, the follow-up after hospital discharge was not carried out. Therefore, rehabilitation, complications and pharmacologic treatments .007 NS = Non statistically significant different with P > .05. *Statistically significant differences with P < 0.05. ** = Statistically significant differences with P < 0.01. † = Chi square test (χ 2 ) was applied, Bold numbers determine the most significant contribution. Abbreviations: Df, degrees of freedom.
after hospital discharge were not collected. New cohort studies may be necessary in order to describe the status of older adults with hip fracture during the rehabilitation phase. 29 Furthermore, this study did not consider the presence of musculoskeletal alterations in the lower limb such as the myofascial pain syndrome associated to hip fracture. 30 Further interventional studies may be necessary to improve the clinical features of older adults with muscle conditions associated to hip fracture, according to prior studies in other body regions.
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In conclusion, age distributions over 75 years old may determine the functionality, comorbidities, surgical features, baseline pharmacologic treatments, complications and features at hospital discharge for older adults who suffer a hip fracture. 
